These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8652366)
1. Bisphosphonates in multiple myeloma: current status; future perspectives. Jantunen E; Laakso M Br J Haematol; 1996 Jun; 93(3):501-6. PubMed ID: 8652366 [No Abstract] [Full Text] [Related]
2. [Bisphosphonates in the therapy of cancer patients]. Jantunen E; Kumpulainen E Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857 [No Abstract] [Full Text] [Related]
3. Bisphosphonates--role in cancer therapies. Mehrotra B J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811 [No Abstract] [Full Text] [Related]
4. Bisphosphonates in the treatment of malignant bone disease. Berenson JR; Lipton A Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275 [TBL] [Abstract][Full Text] [Related]
5. Use of bisphosphonates in cancer patients. Body JJ; Coleman RE; Piccart M Cancer Treat Rev; 1996 Jul; 22(4):265-87. PubMed ID: 9025784 [No Abstract] [Full Text] [Related]
6. Utility of bisphosphonates in treating bone metastases. Merlini G; Turesson I Med Oncol; 1996 Dec; 13(4):215-21. PubMed ID: 9152972 [TBL] [Abstract][Full Text] [Related]
8. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia]. Delmas PD; Charhon SA; Chapuy MC; Meunier PJ Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018 [No Abstract] [Full Text] [Related]
9. [Bisphosphonates and bone metastases]. Lortholary A; Jadaud E; Berthaud P Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966 [TBL] [Abstract][Full Text] [Related]
10. [Biphosphonates in oncology]. Khosravi Shahi P; Díaz Muñoz de la Espada V An Med Interna; 2005 Nov; 22(11):544-7. PubMed ID: 16454591 [TBL] [Abstract][Full Text] [Related]
11. Metastatic bone disease and the role of bisphosphonates. Ellis MJ Br J Hosp Med; 1996 Oct 2-15; 56(7):339-45. PubMed ID: 8899222 [No Abstract] [Full Text] [Related]
13. The evolving role of bisphosphonates. Theriault RL; Hortobagyi GN Semin Oncol; 2001 Jun; 28(3):284-90. PubMed ID: 11402438 [TBL] [Abstract][Full Text] [Related]
14. Pamidronate in the treatment of bone metastases--the European experience. Ford JF Br J Clin Pract Suppl; 1996 Sep; 87():3-4; discussion 13-4. PubMed ID: 8995009 [No Abstract] [Full Text] [Related]
15. Use of dichloromethylene diphosphonate in metastatic bone disease. Jung A; Chantraine A; Donath A; van Ouwenaller C; Turnill D; Mermillod B; Kitler ME N Engl J Med; 1983 Jun; 308(25):1499-501. PubMed ID: 6222257 [TBL] [Abstract][Full Text] [Related]
16. [Current use of bisphosphonates in clinical oncology]. Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372 [TBL] [Abstract][Full Text] [Related]